Iris BioTechnologies Inc. (IRSB):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Iris BioTechnologies Inc. (IRSB) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH282665FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,300見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,600見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Iris BioTechnologies Inc. (Iris BioTechnologies) is a biotechnology company. It focuses on the development and commercialization of Nano-Biochips and an artificial intelligence system, which assists in establishing the foundation for personalized medicine, in the treatment of breast cancer. The company’s products include breastcancerchip and other pipeline products such as, human organ transplant chip, neurochip, cardiochip, and metabolicchip. Iris BioTechnologies’s technology portfolio encompasses biowindows, a diagnostic and prognostic system used to determine the apt therapy based on genomic and family history. Its nano-biochips and BioWindows medical informatics system capture mRNA, proteins, microRNA, and biomarkers and analyze the alterations in cancer pathways. Iris BioTechnologies is headquartered in California, the US.

Iris BioTechnologies Inc. Key Recent Developments

Oct 29, 2013: Iris BioTechnologies Appoints Paul Yaswen, Ph.D. as Chief Scientific Officer

This comprehensive SWOT profile of Iris BioTechnologies Inc. provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Iris BioTechnologies Inc. including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Iris BioTechnologies Inc. – Key Information
Iris BioTechnologies Inc. – Overview
Iris BioTechnologies Inc. – Key Employees
Iris BioTechnologies Inc. – Key Employee Biographies
Iris BioTechnologies Inc. – Key Operational Heads
Iris BioTechnologies Inc. – Major Products and Services
Iris BioTechnologies Inc. – History
Iris BioTechnologies Inc. – Company Statement
Iris BioTechnologies Inc. – Locations And Subsidiaries
Iris BioTechnologies Inc. – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Iris BioTechnologies Inc. – Business Description
Iris BioTechnologies Inc. – Corporate Strategy
Iris BioTechnologies Inc. – SWOT Analysis
SWOT Analysis – Overview
Iris BioTechnologies Inc. – Strengths
Iris BioTechnologies Inc. – Weaknesses
Iris BioTechnologies Inc. – Opportunities
Iris BioTechnologies Inc. – Threats
Iris BioTechnologies Inc. – Key Competitors

Section 3 – Company Financial Performance Charts

Iris BioTechnologies Inc. – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Iris BioTechnologies Inc., Key Information
Iris BioTechnologies Inc., Key Ratios
Iris BioTechnologies Inc., Share Data
Iris BioTechnologies Inc., Major Products and Services
Iris BioTechnologies Inc., History
Iris BioTechnologies Inc., Key Employees
Iris BioTechnologies Inc., Key Employee Biographies
Iris BioTechnologies Inc., Key Operational Heads
Iris BioTechnologies Inc., Other Locations
Iris BioTechnologies Inc., Subsidiaries
Iris BioTechnologies Inc., Key Manufacturing facilities
Iris BioTechnologies Inc., Key Competitors
Iris BioTechnologies Inc., SWOT Analysis
Iris BioTechnologies Inc., Ratios based on current share price
Iris BioTechnologies Inc., Annual Ratios
Iris BioTechnologies Inc., Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Iris BioTechnologies Inc., Performance Chart
Iris BioTechnologies Inc., Ratio Charts

★海外企業調査レポート[Iris BioTechnologies Inc. (IRSB):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Tokyo Electric Power Company, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' The Tokyo Electric Power Compan …
  • Everest Kanto Cylinder Limited (EKC):企業概要、財務及び戦略的SWOT分析
    Summary Everest Kanto Cylinder Limited (EKCL) develops, manufactures and distributes industrial and CNG cylinders. Its products include industrial cylinder, allied products, medical cylinder, beverage cylinder, CNG cylinder, and accumulator. EKCL offers allied products such as cylinder valves, valve …
  • Selcuk Ecza Deposu Ticaret ve Sanayi AS (SELEC):企業財務及び戦略的SWOT分析
    Summary Selcuk Ecza Deposu Ticaret ve Sanayi AS (Selcuk Ecza) manufactures drugs and operates pharmacies. The company's pharmaceutical products include cosmetics, personal care, infant food, vitamins, medical, and other products. It organizes the distribution channels between the drug manufacturers, …
  • Great American Group, LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Great American Group, LLC Merge …
  • Brenntag AG (formerly Brenntag Management GmbH):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Brenntag AG (formerly Brenntag …
  • Petro Matad Limited (MATD):企業概要、財務及び戦略的SWOT分析
    Summary Petro Matad Limited (Petro Matad) is an upstream oil and gas company. The company explores for develops and produces oil and gas from its assets in Mongolia. Petro Matad holds a total area of 60,000 sq. km. Its upstream oil and gas asset base comprised of Matad Block XX, Bogd Block IV, and O …
  • KITO Corporation (6409):企業の財務及び戦略的SWOT分析
    Summary KITO Corporation (KITO), a subsidiary of Carlyle Investment Management L.L.C. is an engineering equipment company that provides manufacturing; construction; sales; repair and maintenance of material handling equipments. The company offers products which include hoists, cranes, slings and ele …
  • Deva Holding A.S. (DEVA):企業概要、財務及び戦略的SWOT分析
    Summary Deva Holding A.S. (Deva) is a pharmaceutical company. The company manufactures and markets human pharmaceuticals and active pharmaceutical ingredient (API) for human health. It produces and sells veterinary drugs, cologne, medical vials and agrochemicals. Deva offers products, such as adrimi …
  • Genesis Invest AGの企業概要及び財務/SWOT分析
    Genesis Invest AG Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly for …
  • Biocrates Life Sciences AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Biocrates Life Sciences AG Merg …
  • IntelGenx Corp.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' IntelGenx Corp. Mergers and Acq …
  • EPIX Pharmaceuticals, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' EPIX Pharmaceuticals, Inc. Merg …
  • Renown Incorporated:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Renown Incorporated Mergers and …
  • Bionure Farma SL-製薬・医療分野:企業M&A・提携分析
    Summary Bionure Farma SL (Bionure) is a healthcare service provider that provides treatment for ophthalmological diseases, with concentration on multiple sclerosis and glaucoma. The company concentrates on two conditions of vision impairment which include optic neuritis and neuromyelitis optica. Its …
  • Energy Focus, Inc. (EFOI)-エネルギー分野:企業M&A・提携分析
    Summary Energy Focus, Inc. (Energy Focus) is a provider of energy efficient LED lighting products and technologies. The company, together with its subsidiaries, designs, develops, manufactures, markets, and installs energy-efficient lighting systems and solutions. Its military maritime products incl …
  • Revance Therapeutics Inc (RVNC):企業財務及び戦略的SWOT分析
    Summary Revance Therapeutics Inc (Revance) is a bio-pharmaceutical company that develops, manufactures and commercializes novel botulinum toxin products. The company’s products comprise RT001, a physician-applied topical botulinum toxin type A (BoNT-A) for cosmetic, hyperhidrosis, and dermatologic i …
  • DRB-HICOM Berhad:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' DRB-HICOM Berhad Mergers and Ac …
  • Humana Inc (HUM)-医療機器分野:企業M&A・提携分析
    Summary Humana Inc (Humana) is a health and well-being company that offers health insurance and Medicare plans, insurance products, and health and wellness services to healthcare providers, employers, individuals, administrators, government, and the public sector. The company’s Medicare products and …
  • GCL-Poly Energy Holdings Ltd. (3800):企業のM&A・提携動向(発電分野)
    Summary GCL-Poly Energy Holdings Ltd. (GCL) is a provider of solar photovoltaic (PV) material and professional PV system solutions. The company produces polysilicon and wafer, and sells them to solar companies. It also provides solar project development, design, procurement, construction, financing, …
  • Agenix Limited (AGX):企業のM&A・提携動向(医療機器分野)
    Summary Agenix Limited (Agenix) is a biotechnology company. It develops small molecule drugs and monoclonal antibody-based diagnostics for the treatment of various diseases. The company developed DiagnostIQ rapid point-of-care human diagnostic technology and Thromboview patented technetium-99m-label …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆